OCTOBER 2024: 

Loma engages with key stakeholders in Kenya. 

We are thrilled to share highlights from our recent visit to Kenya, where our team had the privilege of meeting with influential local stakeholders to discuss our work on developing a therapeutic vaccine for HPV+ cancers. This visit was an important step in expanding our understanding of the healthcare landscape in East Africa and exploring how our technology can address the unique needs of communities affected by HPV-related cancers. 

During our time in Kenya, we connected with healthcare leaders, policy makers, researchers, and community advocates dedicated to advancing cancer care. Our discussions focused on collaborative opportunities, the potential of our therapeutic vaccine, and how we can tailor our approach to maximize accessibility and impact within the region. The insights gained from these conversations are invaluable as we work to align our development with the needs of communities in Kenya and beyond. 

We are deeply grateful to our Kenyan hosts and partners for their warm welcome and for sharing their expertise and perspectives. This visit has reaffirmed our commitment to delivering impactful health solutions on a global scale, and we are looking forward to building on these connections to bring transformative therapies to underserved populations. 

Thank you to everyone in Kenya who shared their time and insights with us. We look forward to the collaborative journey ahead and to making a meaningful difference together.